Rheumatoid Arthritis: A Clinical Review (Technician)
![](https://www.ceimpact.com/wp-content/uploads/course-images/2023/07/marketplace/woo-5604-768x768.jpg)
Rheumatoid Arthritis: A Clinical Review (Technician)
For the first time in 6 years, the American College of Rheumatology published new guidelines for the treatment of rheumatoid arthritis. With 1.3 million Americans currently diagnosed with Rheumatoid Arthritis, this specialty condition often finds itself being managed in multiple sites of care. Learn how pharmacy contributes to the team care of RA patients with this guideline update.
Upon successful completion of this application-based CPE course, pharmacy technicians should be able to:
1. List the signs and symptoms of rheumatoid arthritis
2. Identify commonly used medications for the treatment of rheumatoid arthritis
3. Determine eligible patients for disease activity scale assessment
4. Assess the medication profile of patients with rheumatoid arthritis for potential common adverse reactions of disease-modifying antirheumatic drugs (DMARDS)
Jonathan Ogurchak, PharmD, CSP
STACK, CEO
Jonathan Ogurchak does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
Financial support was provided for this course through an unrestricted educational grant from Biologics by McKesson.
Course includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable
Initial Release Date: September 16, 2021
Planned Expiration Date: September 16, 2024
Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.
RV3-4.24/EXP
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
Duration | 1h 0m |
---|---|
Topic Designator | Disease State/Drug Therapy |
ACPE | Yes |
ACPE Topic | 01 Drug Therapy |
Role | Technician |
Media-Type | On-Demand |
Release Date | 9/17/21 |
CEUs | 0.1 |
Rating | 4 |
ACPE Number | 0107-0000-21-207-H01-T |
This course is in our subscription.
Related products
-
A Non-irritable Review of Irritable Bowel Syndrome (IBS) Guidelines
In Courses, PharmacistRated 0 out of 5$24.00 -
-
Avelumab for Urothelial Carcinoma – Improving Overall Survival?
In Courses, PharmacistRated 0 out of 5$24.00